Table 2 FUMA top 10 gene ontology (GO) and canonical pathway enrichment categories of ~1,183 genes that map to differentially methylated probes in primary EWAS (left) and comparable gene list from supplementary EWAS that included all CpGs regardless of blood-brain correlation (right).

From: Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorder

RANK

Gene set

N overlap (N genes)

p

adjP

Gene Set

N overlap (N genes)

p

adjP

 

Primary EWAS (blood-brain correlated CpGs)a

Supplementary EWAS (all CpGs)a

GO biological processes

1

Biological adhesionb

128 (1404)

7.88E−26

5.79E−22

Neurogenesis

152 (1594)

1.70E−32

1.25E−28

2

Homophilic cell adhesion via plasma membrane adhesion molecules

41 (165)

1.37E−24

5.04E−21

Neuron differentiation

128 (1343)

2.47E−27

9.08E−24

3

Cell–cell signalling

137 (1638)

4.77E−24

1.17E−20

Positive regulation of biosynthetic process

160 (1966)

1.78E−26

4.37E−23

4

Cell–cell adhesion via plasma membrane adhesion molecules

50 (271)

2.20E−23

4.05E−20

Positive regulation of gene expression

154 (1955)

4.99E−24

9.18E−21

5

Cell–cell adhesion

87 (819)

4.78E−22

7.03E−19

Central nervous system development

99 (972)

2.25E−23

3.31E−20

6

Synaptic signalling

73 (712)

8.10E−18

9.92E−15

Sensory organ development

70 (535)

7.72E−23

9.46E−20

7

Ion transport

121 (1663)

1.53E−16

1.61E−13

Positive regulation of RNA biosynthetic process

132 (1592)

1.43E−22

1.51E−19

8

Positive regulation of molecular function

121 (1740)

4.19E−15

3.85E−12

Animal organ morphogenesis

100 (1030)

4.63E−22

4.25E−19

9

Synapse assembly

31 (175)

1.63E−14

1.33E−11

Biological adhesionb

120 (1404)

1.24E−21

1.01E−18

10

Synapse organization

47 (404)

6.41E−14

4.71E−11

Growth

96 (979)

1.62E−21

1.19E−18

GO cellular components

1

Intrinsic component of plasma membrane

145 (1697)

2.26E−26

2.26E−23

Neuron partb

150 (1709)

3.48E−28

3.48E−25

2

Synapseb

107 (1169)

8.30E−22

4.16E−19

Cell junctionb

113 (1275)

1.23E−21

6.17E−19

3

Neuron partb

130 (1709)

2.66E−19

8.88E−17

Plasma membrane regionb

104 (1185)

1.16E−19

3.14E−17

4

Cell junctionb

106 (1275)

1.53E−18

3.83E−16

Synapseb

103 (1169)

1.33E−19

3.14E−17

5

Synapse partb

85 (932)

2.05E−17

4.11E−15

Neuron projectionb

110 (1301)

1.57E−19

3.14E−17

6

Neuron projectionb

102 (1301)

3.68E−16

6.15E−14

Cell projection partb

115 (1438)

1.56E−18

2.60E−16

7

Plasma membrane regionb

94 (1185)

2.81E−15

4.01E−13

Intrinsic component of plasma membrane

124 (1697)

7.63E−17

1.09E−14

8

Postsynapse

61 (610)

1.35E−14

1.68E−12

Somatodendritic compartment

77 (818)

1.82E−16

2.27E−14

9

Cell projection partb

103 (1438)

8.84E−14

9.84E−12

Cytoskeletal part

119 (1639)

5.43E−16

6.04E−14

10

Whole membrane

111 (1647)

4.82E−13

4.82E−11

Synapse partb

81 (932)

2.69E−15

2.70E−13

GO molecular function

1

Calcium ion binding

79 (693)

5.41E−22

8.91E−19

Sequence-specific DNA bindingb

106 (1114)

1.15E−22

1.90E−19

2

Ribonucleotide bindingb

123 (1885)

2.23E−13

1.83E−10

Regulatory region nucleic acid bindingb

91 (934)

2.96E−20

2.43E−17

3

Drug bindingb

112 (1718)

3.09E−12

1.70E−09

DNA binding transcription factor activity

128 (1691)

1.37E−18

7.49E−16

4

Adenyl nucleotide binding

101 (1536)

2.41E−11

9.91E-09

Sequence-specific double-stranded DNA bindingb

83 (860)

2.59E−18

1.06E−15

5

Sequence-specific DNA bindingb

78 (1114)

3.01E−10

9.28E−08

Double-stranded DNA bindingb

88 (952)

3.60E−18

1.19E−15

6

Regulatory region nucleic acid bindingb

69 (934)

3.54E−10

9.28E−08

Drug bindingb

125 (1718)

7.84E−17

2.01E−14

7

Transmembrane transporter activity

74 (1038)

3.95E−10

9.28E−08

Ribonucleotide bindingb

133 (1885)

8.55E−17

2.01E−14

8

Double-stranded DNA bindingb

69 (952)

7.90E−10

1.62E−07

Adenyl nucleotide binding

114 (1536)

5.06E−16

1.04E−13

9

Sequence-specific double-stranded DNA bindingb

64 (860)

1.17E−09

2.13E−07

Cytoskeletal protein binding

83 (948)

7.90E−16

1.44E−13

10

Ion transmembrane transporter activity

64 (870)

1.84E−09

2.76E−07

Identical protein binding

118 (1706)

2.24E−14

3.69E−12

Canonical pathways (Reactome)

1

Neuronal systemb

52 (410)

7.87E−17

1.73E−13

Neuronal systemb

44 (410)

8.06E−12

1.77E−08

2

Protein proteinb interactions at synapses

21 (87)

5.20E−13

5.71E−10

Extracellular matrix organization

35 (299)

1.03E−10

1.13E−07

3

Transmission across chemical synapsesb

33 (269)

8.46E−11

6.20E−08

Transport of small molecules

55 (728)

1.31E−08

9.61E−06

4

Neurotransmitter receptors and postsynaptic signal transmissionb

28 (204)

1.66E−10

9.10E−08

Axon guidance

45 (551)

2.90E−08

1.38E−05

5

Neurexins and neuroligins

15 (56)

2.21E−10

9.71E−08

Developmental biology

72 (1100)

3.14E−08

1.38E−05

6

Activation of NMDA receptors and postsynaptic events

17 (92)

6.95E−09

2.55E−06

NABA matrisomeb

68 (1024)

4.42E−08

1.62E−05

7

Disease

68 (1072)

1.88E−07

5.92E−05

Signalling by receptor tyrosine kinases

39 (468)

1.43E−07

4.17E−05

8

NABA core matrisomeb

26 (274)

1.39E−06

0.000382

Protein protein interactions at synapsesb

15 (87)

1.52E−07

4.17E−05

9

CREB1 phosphorylation through NMDAR-mediated activation of RAS signalling

8 (28)

2.21E−06

0.00054

Neurotransmitter receptors and postsynaptic signal transmissionb

23 (204)

3.14E−07

7.29E−05

10

GPCR ligand binding

35 (453)

2.94E−06

0.000598

Transmission across chemical synapsesb

27 (269)

3.32E−07

7.29E−05

  1. RANK rank of enrichment category on the basis of adjusted p-value, N genes number of genes in category, N overlap number of DMP genes in category. DMP differentially methylated position, P p value, adjP adjusted p value.
  2. aData are presented for an equivalent number of genes in both primary and supplementary EWAS that map to differentially methylated probes. Full outputs of GO and canonical pathway enrichment are provided in Tables S4 and S7.
  3. bCategories that are represented in top 10 for both primary EWAS using blood-brain selected probes, and unselected supplementary EWAS.